MET and cancer: Furthermore, the plasticity in various cancers is modulated through an intricate network of signaling pathways such as Notch, IGF-II/IGF1R, c-Met/FRA1/HEY1, and FAK, primarily driven by fibroblasts and CAFs originating from MSCs [53].